Abstract: A monitoring system for a vehicle includes a plurality of surveillance sensors in connection with the vehicle and configured to capture sensor data proximate to the vehicle. A position sensor is configured to detect a location of the vehicle. A controller determines a surveillance mode for the vehicle based on the sensor data and a plurality of security factors associated with the location of the vehicle. The controller activates the surveillance mode in response to the security factors and monitors the sensor data. The controller further filters a plurality of security events from a plurality of benign events and selectively outputs alerts in response to the security events and the benign events.

Abstract: The present disclosure relates to the field of a pill dispenser. The pill dispenser with a pre-filled stackable cartridge comprises a top plate, fitted horizontally with an embedded machine device; a cartridge assembly, fitted horizontally and mounted vertically on top of each of the cartridge assembly, detachably supporting a set of the pre-filled stackable cartridge wherein each of the cartridge comprise a plurality of slots to place a pill and a pill dispensing slot for dispensing the pill; and a plurality of tabs attached externally to each of the cartridge wherein one of the tab remains intact and rest each of the tabs are broken to create at least one hole to denote a serial number of the cartridge to follow a sequence of mounting the cartridge, a base plate comprising a pill cup to be manually pulled by the consumer to extract the pill to be consumed.

Abstract: Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I? and I?? or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.

Abstract: Macrocyclic Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, Formula V, Formula VI, Formula VII, and Formula VIII or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

Abstract: A method implements customizable gesture commands. The method includes constructing a set of gesture containers and training a machine learning model, for a gesture container of the set of gesture containers, to detect a performance of a video gesture. The method further includes detecting the performance of the video gesture, from a gesture container of the set of gesture containers, in a video stream using the machine learning model. The method further includes executing, in response to detecting the video gesture, a command assigned to the video gesture by the gesture container.

Abstract: A method may include obtaining, using a head detection model and for an image in a video stream, head detection information on the video stream, identifying a group vertical size of a group on a vertical axis using the head detection information, and identifying a group horizontal size of the group on a horizontal axis using the head detection information. Method may in addition include determining an orientation of the group using the group horizontal size and group vertical size, creating a group frame definition using the orientation, and outputting the video stream using the group frame definition.

Abstract: A method may include obtaining, using a head detection model and for an image of a video stream, head detection information, where the head detection information identifies heads detected in the image, selecting a set of templates for the heads, and creating, individually, head frame definitions for the heads using the set of templates. The method may processing the video stream using the head frame definitions.

Abstract: A method may include obtaining, using a head detection model and for an image of a video stream, head detection information, where the head detection information identifies heads detected in the image. Method may also include obtaining buffer bounding boxes. Obtaining the buffer bounding boxes may include obtaining head buffer bounding boxes for the heads detected in the image, and combining at least two of the head buffer bounding boxes into a proximity buffer bounding box. The method may furthermore include identifying a set of templates based on the buffer bounding boxes. Method may in addition include creating, individually, head frame definitions for the buffer bounding boxes using the set of templates, generating an image frame definition that combines the head frame definitions, and processing the video stream using the image frame definition.

Abstract: An embodiment involves persistent storage and one or more processors. The persistent storage may contain a plurality of hardware models specifying types of computing devices, wherein the hardware models include attributes representing manufacturer names, product names, and model numbers of the computing devices. The processors may be configured to: obtain, from the persistent storage, a hardware model; calculate a hash value over attributes of the hardware model; compare the hash value to hash values in a curated list, the curated list including normalized hardware models that map the hash values to normalized manufacturer names, normalized product names, or normalized model numbers; determine that the hash value matches a particular hash value for a normalized hardware model; and update, in the persistent storage, the hardware model to include at least one of a normalized manufacturer name, a normalized product name, or a normalized model number associated with the normalized hardware model.

Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade. The inhibitors of factor D described herein reduce excessive activation of complement.

Abstract: Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

Abstract: The present disclosure relates to the field of a pill dispenser. The pill dispenser with a pre-filled stackable cartridge comprises a top plate, fitted horizontally with an embedded machine device; a cartridge assembly, fitted horizontally and mounted vertically on top of each of the cartridge assembly, detachably supporting a set of the pre-filled stackable cartridge wherein each of the cartridge comprise a plurality of slots to place a pill and a pill dispensing slot for dispensing the pill; and a plurality of tabs attached externally to each of the cartridge wherein one of the tab remains intact and rest each of the tabs are broken to create at least one hole to denote a serial number of the cartridge to follow a sequence of mounting the cartridge, a base plate comprising a pill cup to be manually pulled by the consumer to extract the pill to be consumed.

Abstract: Systems and techniques are described herein for processing images. The systems and techniques can be implemented by various types of systems, such as by an extended reality (XR) system or device. In some cases, a first processor receives an image of an environment captured by an image sensor, identifies features depicted in the image, and generates descriptors for the features. The first processor sends the descriptors to a second processor, which may be more powerful than the first processor. The second processor receives the descriptors. The second processor associates the plurality of features with a map of the environment based on at least a subset of the plurality of descriptors. For example, the second processor can track at least a subset of the features based on at least a subset of the descriptors and based on feature information from one or more additional images of the environment.

Abstract: Compounds, methods of use, and processes for making inhibitors of complement Factor comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.

Abstract: Macrocyclic Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, Formula V, Formula VI, Formula VII, and Formula VIII or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

Abstract: A method implements customizable gesture commands. The method includes constructing a set of gesture containers and training a machine learning model, for a gesture container of the set of gesture containers, to detect a performance of a video gesture. The method further includes detecting the performance of the video gesture, from a gesture container of the set of gesture containers, in a video stream using the machine learning model. The method further includes executing, in response to detecting the video gesture, a command assigned to the video gesture by the gesture container.

Abstract: Methods and systems for providing software applications on a client device with dynamic control over low-latency mode (LLM) operations of the client device. The client device may monitor downlink data packets of a client software application operating on the client device to detect trigger events. The client device may determine operating parameters of the modem based on a detected trigger event and dynamically adjust the low-latency mode of the modem based on the detect trigger event or the determined operating parameters.

Abstract: Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

Abstract: The present disclosure relates to methods and apparatus for video processing. In one aspect, the apparatus may configure at least one frame of plurality of frames in a video stream. The apparatus may also divide the at least one frame into one or more slices, each of the one or more slices including one or more data packets. The apparatus may also map each of the one or more slices to one of one or more communication channels. The apparatus may also transmit each of the one or more slices including the one or more data packets via the one of the one or more communication channels. In another aspect, the apparatus may receive each of one or more slices via one of one or more communication channels. The apparatus may also decode each of the one or more slices including one or more data packets.

Abstract: Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I? and I?? or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.